Literature DB >> 16982883

CpG DNA activates survival in murine macrophages through TLR9 and the phosphatidylinositol 3-kinase-Akt pathway.

David P Sester1, Kristian Brion, Angela Trieu, Helen S Goodridge, Tara L Roberts, Jasmyn Dunn, David A Hume, Katryn J Stacey, Matthew J Sweet.   

Abstract

Bacterial CpG-containing (CpG) DNA promotes survival of murine macrophages and triggers production of proinflammatory mediators. The CpG DNA-induced inflammatory response is mediated via TLR9, whereas a recent study reported that activation of the Akt prosurvival pathway occurs via DNA-dependent protein kinase (DNA-PK) and independently of TLR9. We show, in this study, that Akt activation and survival of murine bone marrow-derived macrophages (BMM) triggered by CpG-containing phosphodiester oligodeoxynucleotides or CpG-containing phosphorothioate oligodeoxynucleotides was completely dependent on TLR9. In addition, survival triggered by CpG-containing phosphodiester oligodeoxynucleotides was not compromised in BMM from SCID mice that express a catalytically inactive form of DNA-PK. CpG DNA-induced survival of BMM was inhibited by the PI3K inhibitor, LY294002, but not by the MEK1/2 inhibitor, PD98059. The effect of LY294002 was specific to survival, because treatment of BMM with LY294002 affected CpG DNA-induced TNF-alpha production only modestly. Therefore, CpG DNA activates macrophage survival via TLR9 and the PI3K-Akt pathway and independently of DNA-PK and MEK-ERK.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982883     DOI: 10.4049/jimmunol.177.7.4473

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  TLR7 and TLR9 ligands regulate antigen presentation by macrophages.

Authors:  Teja Celhar; Selma Pereira-Lopes; Susannah I Thornhill; Hui Yin Lee; Manprit K Dhillon; Michael Poidinger; John E Connolly; Lina H K Lim; Subhra K Biswas; Anna-Marie Fairhurst
Journal:  Int Immunol       Date:  2015-11-13       Impact factor: 4.823

2.  Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.

Authors:  Valentina Di Caro; Antonella D'Anneo; Brett Phillips; Carl Engman; Jo Harnaha; Massimo Trucco; Nick Giannoukakis
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

3.  Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes.

Authors:  Wing Ki Cheng; Kathleen Wee; Tobias R Kollmann; Jan P Dutz
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

4.  B Cells Produce Type 1 IFNs in Response to the TLR9 Agonist CpG-A Conjugated to Cationic Lipids.

Authors:  Munir Akkaya; Billur Akkaya; Pietro Miozzo; Mukul Rawat; Mirna Pena; Patrick W Sheehan; Ann S Kim; Olena Kamenyeva; Juraj Kabat; Silvia Bolland; Akanksha Chaturvedi; Susan K Pierce
Journal:  J Immunol       Date:  2017-06-26       Impact factor: 5.422

5.  Molecular mechanism for p202-mediated specific inhibition of AIM2 inflammasome activation.

Authors:  Qian Yin; David P Sester; Yuan Tian; Yu-Shan Hsiao; Alvin Lu; Jasmyn A Cridland; Vitaliya Sagulenko; Sara J Thygesen; Divaker Choubey; Veit Hornung; Thomas Walz; Katryn J Stacey; Hao Wu
Journal:  Cell Rep       Date:  2013-07-11       Impact factor: 9.423

6.  TLR2-deficiency of cKit+ bone marrow cells is associated with augmented potency to stimulate angiogenic processes.

Authors:  Nana-Maria Wagner; Laura Bierhansl; Antje Butschkau; Gabriele Noeldge-Schomburg; Jan Patrick Roesner; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

7.  Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis.

Authors:  Soumya Panigrahi; Yi Ma; Li Hong; Detao Gao; Xiaoxia Z West; Robert G Salomon; Tatiana V Byzova; Eugene A Podrez
Journal:  Circ Res       Date:  2012-10-15       Impact factor: 17.367

8.  CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling.

Authors:  Makoto Ishii; Cory M Hogaboam; Amrita Joshi; Toshihiro Ito; Daniel J Fong; Steven L Kunkel
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

9.  The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling.

Authors:  Ming Gao; Tuanzhu Ha; Xia Zhang; Xiaohui Wang; Li Liu; John Kalbfleisch; Krishna Singh; David Williams; Chuanfu Li
Journal:  J Infect Dis       Date:  2013-01-28       Impact factor: 5.226

10.  CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling.

Authors:  Zhijuan Cao; Danyang Ren; Tuanzhu Ha; Li Liu; Xiaohui Wang; John Kalbfleisch; Xiang Gao; Race Kao; David Williams; Chuanfu Li
Journal:  Biochim Biophys Acta       Date:  2012-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.